Knight is a multinational specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for Canada and Latin America
Ticker:
GUD
Exchange:
TSX
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
Quebec
Company HQ Country:
Canada
Year Founded:
Not Provided
Main Therapeutic Focus:
Oncology
Lead Product in Development:
Multiple products
Development Phase of Primary Product:
Multiple Products in Market
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided